Bilateral sudden hearing loss following ABVD protocol.
Department of Hematology, CHU Mohamed VI, Cadi Ayyad University, Marrakech, Morocco.
I
I
Tazi
H
H
Nafil
L
L
Mahmal
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D003606:Dacarbazine / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D003639:Hearing Loss, Sudden / Q000175:diagnosis / Q000209:etiology*; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use
D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin